Abbott to pay $670 million to settle some preterm infant formula cases

August 21, 2026
The settlement was agreed to by three law firms representing about 2,000 people with claims against Abbott, including one Illinois mother who won a $495 million judgment in 2024 after a jury concluded that Abbott’s formula caused her daughter to develop necrotizing ‌enterocolitis, a dangerous ⁠bowel disease. Abbott ⁠agreed to drop its efforts to appeal that verdict, which had been upheld by a Missouri appeals court in May 2026.